Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)

University of California, Los Angeles (UCLA)

Status

Conditions: Dravet Syndrome

Treatments: Drug: Fenfluramine

Study type: Expanded Access

Funder types: Other

Identifiers

NCT04437004

ZX008-1800

Details and patient eligibility

About

The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.

Full description

The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.

Sex: All

Ages: 2+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Genetic diagnosis of Dravet syndrome with intractable seizures despite failing all available medications for seizures.